Assessing long‐term upgrade risks in recurrent low‐grade non‐muscle‐invasive bladder cancer, can we deintensify the treatment?
Alessio Finocchiaro,
Marco Paciotti,
Roberto Contieri
et al.
Abstract:When treating patients with low-grade (LG) non-muscleinvasive bladder cancer (NMIBC), urologists must carefully balance follow-up schedules and interventions to avoid overtreatment without compromising oncological safety.
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.